Larson Financial Group »

Candel Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $134 13 10.31

More positions owned by Larson Financial Group

Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Apple (AAPL)
Applied Materials (AMAT)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Capital Grp Fixed Incm Etf T Core Bond Etf (CGCB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Lam Research Corp Com New (LRCX)

View all positions for Larson Financial Group

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics